ArticleNeurology(R) neuroimmunology & neuroinflammation2021

Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS.

José I Fernández-Velasco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.